Treatment Modalities in Oral Cancer: Current Practices and Future Perspectives
International Journal of Innovative Science and Research Technology · 09.04.2026 · 225
DOI: 10.38124/ijisrt/26apr162 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 09.04.2026. Verfasst von E. Bala Krishna Gowd und 4 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is a major global health concern, particularly in developing countries, with significant morbidity and mortality (1–3). Despite advances in diagnostic and therapeutic strategies, the overall 5-year survival rate remains approximately 50–60%, largely due to late-stage diagnosis, recurrence, and therapeutic resistance (1,4). Major risk factors include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection (5,6). The pathogenesis of oral cancer involves complex molecular mechanisms, including genetic mutations and dysregulation of key signaling pathways such as p53 and EGFR, contributing to tumor progression and metastasis (7,8). Conventional treatment modalities—surgery, radiotherapy, and chemotherapy—remain the cornerstone of management (9,12,14). However, these approaches are often associated with significant toxicity and functional impairment. Recent advances in treatment strategies have introduced targeted therapy and immunotherapy as promising alternatives. Agents such as cetuximab and immune checkpoint inhibitors, including nivolumab and pembrolizumab, have demonstrated improved outcomes in advanced and recurrent cases (16–18). Additionally, emerging approaches such as gene therapy, photodynamic therapy, and nanotechnology-based drug delivery systems offer new avenues for improving therapeutic efficacy and reducing systemic toxicity (19–21). The integration of precision medicine, based on molecular profiling and biomarker identification, is further transforming oral cancer management by enabling personalized treatment strategies (22). This review highlights current treatment modalities and explores future directions aimed at improving survival and quality of life in patients with oral cancer.
Zitieren
APA
Gowd, E. B. K., Ramachandra, M. S., Reddy, B. S., Ahmed, M. M., & Moulali, P. (2026). Treatment Modalities in Oral Cancer: Current Practices and Future Perspectives. International Journal of Innovative Science and Research Technology, 225. https://doi.org/10.38124/ijisrt/26apr162
Vancouver
Gowd EBK, Ramachandra MS, Reddy BS, Ahmed MM, Moulali P. Treatment Modalities in Oral Cancer: Current Practices and Future Perspectives. International Journal of Innovative Science and Research Technology. 2026:225. doi:10.38124/ijisrt/26apr162
BibTeX
@article{Gowd2026,
author = {Gowd, E. Bala Krishna and Ramachandra, M. Sri and Reddy, B. Sneha and Ahmed, Md. Musheed and Moulali, P.},
title = {Treatment Modalities in Oral Cancer: Current Practices and Future Perspectives},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {225},
doi = {10.38124/ijisrt/26apr162}
}
EUVIMED